To further client goals, Arianne serves as a scientific communicator when the law and biology intersect.
Arianne is a biologist and chemist who has researched, taught, published, spoke, collaborated with startups, and provided outreach and professional development in her field. Working closely with legal teams, she serves as a translator and analytical problem solver, primarily in the patent litigation sector. Arianne has experience in preparing Paragraph IV filings for generic versions of branded drugs, as well as research and analysis experience when PIV filings are challenged. Her research often leads to a victory or settlement, resulting in getting generic drugs to market faster and saving litigation costs for clients.
If a patent challenge results in litigation, Arianne assists in discovery, works with expert witnesses in testimony preparation and attends court proceedings, conferring with our litigation attorneys to offer further insight and inform their questioning and arguments.
Arianne also researches and advises on patent litigation and prosecution cases involving polymers, medical devices and animal drugs.
Attorneys and clients appreciate Arianne’s ability to proactively bridge gaps when the law intersects with issues of biology and biochemistry.
She assists across a wide range of phases and matters, including:
- Due diligence
- Discovery
- Patent infringement
- Intellectual property matters
- Commercial litigation
- Hatch-Waxman Act
- Generic drug/abbreviated new drug application (ANDA) litigation
- Section 337 and the International Trade Commission (ITC)
- Research misconduct
Curious, detail-oriented, and able to make technical concepts easily understood, Arianne enjoys working on matters such as bringing a cost-effective generic drug to market or protecting a client’s intellectual property.